Infertility Testing Market by Test Type (Ovulation Testing Kits, Hormonal Testing Kits, Semen Analysis Kits); Application (Female Infertility Testing, Male Infertility Testing); End-Use Industry (Fertility Clinics, Hospitals, Diagnostic Laboratories) and by Region; Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Infertility Testing Market was valued at USD 1.2 Billion in 2024-e and will surpass USD 2.2 Billion by 2030; growing at a CAGR of 10.8% during 2025 - 2030.

The Infertility Testing Market has seen significant growth in recent years, driven by the increasing awareness of infertility issues and the rising demand for early detection of reproductive health problems. Infertility is a common concern affecting both men and women, and as more individuals seek solutions, the market for infertility testing has expanded. With a variety of test types available, such as ovulation testing kits, hormonal testing kits, and semen analysis kits, the market provides individuals and healthcare professionals with tools to assess fertility health. The rise of at-home testing kits, which offer privacy and convenience, alongside advanced diagnostic solutions in clinical settings, has further fueled the demand for infertility testing.

As the societal acceptance of fertility treatments grows and the awareness of infertility-related issues increases, the market is expected to continue its expansion. Additionally, more couples are choosing to test for infertility earlier, driving the demand for both male and female infertility testing services. Fertility clinics, diagnostic laboratories, and hospitals have become central players in the delivery of these services, providing accurate and timely testing for patients who seek answers to their fertility challenges.

Ovulation Testing Kits Are Largest Test Type Owing to Their Accessibility and Affordability

Ovulation testing kits are the largest segment in the infertility testing market due to their accessibility, affordability, and widespread use among women who are actively trying to conceive. These kits are designed to detect the surge in luteinizing hormone (LH) that precedes ovulation, helping women identify their most fertile days. This empowers individuals with the knowledge needed to time intercourse and increase their chances of pregnancy. The simplicity and ease of use of ovulation testing kits make them highly popular among women who prefer to monitor their fertility at home.

Ovulation kits are available over-the-counter in most pharmacies and are affordable, which has significantly contributed to their large market share. Additionally, the growing trend of self-care and home-based healthcare solutions has further driven the adoption of these kits. As they are often the first step in fertility testing, ovulation testing kits play a key role in the early detection of fertility issues, contributing to their dominance in the infertility testing market.

Semen Analysis Kits Are Fastest Growing Test Type Due to Increased Focus on Male Fertility

Semen analysis kits represent the fastest-growing test type in the infertility testing market, largely driven by the increasing recognition of male fertility issues. While infertility has historically been considered a female concern, a significant proportion of infertility cases are attributed to male factors. Semen analysis kits provide valuable insights into sperm count, motility, and morphology, enabling men to assess their reproductive health. The growing awareness of male infertility and its impact on overall fertility has led to an increased demand for semen analysis, both in clinical settings and for at-home testing.

Technological advancements in semen analysis kits, including the integration of smartphone apps and more accurate testing methods, have contributed to their growing popularity. Additionally, as couples increasingly seek comprehensive fertility evaluations, men are becoming more proactive in seeking fertility testing. This growing focus on male fertility, combined with the convenience and privacy offered by at-home semen analysis kits, is driving the rapid expansion of this segment in the market.

Fertility Clinics Are Largest End-Use Industry Due to Their Focused Fertility Services

Fertility clinics are the largest end-use industry in the infertility testing market, as they specialize in diagnosing and treating infertility. These clinics offer a wide range of services, from basic fertility testing to advanced assisted reproductive technologies (ART) such as in vitro fertilization (IVF). Fertility clinics often provide a comprehensive testing approach that includes both male and female infertility assessments, including semen analysis and hormonal testing. As these clinics cater specifically to individuals seeking fertility solutions, they play a central role in the delivery of infertility testing services.

The growth of fertility clinics is driven by the increasing demand for infertility treatments and the rising awareness of the availability of diagnostic services. Fertility clinics also benefit from the integration of advanced technologies that enable accurate and quick results, making them a primary destination for individuals seeking infertility testing. As more individuals seek professional help with fertility issues, fertility clinics remain the largest sector for infertility testing services.

North America Is Largest Region Owing to High Fertility Treatment Demand

North America is the largest region in the infertility testing market, largely due to the high demand for fertility treatments, increased awareness of infertility issues, and advanced healthcare infrastructure. The United States and Canada have some of the highest rates of fertility testing, driven by rising infertility rates and the growing acceptance of assisted reproductive technologies. The presence of world-class fertility clinics and diagnostic laboratories in North America has further fueled the adoption of infertility testing services.

The region's healthcare system also supports a high level of accessibility to infertility testing, with insurance coverage often extending to diagnostic services related to fertility treatments. Additionally, as the focus on family planning and reproductive health continues to grow, North America is expected to maintain its position as the largest market for infertility testing. The region’s continued investment in fertility research and advancements in diagnostic technology further strengthens its leadership in the global market.

Leading Companies and Competitive Landscape

The infertility testing market is competitive, with several key players offering a range of testing solutions for both male and female infertility. Major companies in the market include Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers, which provide advanced diagnostic products such as ovulation testing kits, hormonal testing kits, and semen analysis kits. These companies leverage their established reputation in the healthcare industry and continue to innovate, focusing on improving the accuracy and user-friendliness of their products.

The competitive landscape is marked by product innovations, strategic partnerships, and increasing research and development efforts to cater to the growing demand for infertility testing services. Additionally, several startups and smaller companies are entering the market, offering unique testing solutions such as home-based kits and mobile-enabled devices. As the market grows, leading companies are likely to continue enhancing their product portfolios and expanding their presence in emerging markets, ensuring robust competition in the years to come.

Recent Developments:

  • Thermo Fisher Scientific launched a new advanced hormonal testing kit for women aiming to detect fertility issues more accurately.
  • CooperSurgical introduced a new semen analysis device, enhancing accuracy and providing quicker results for fertility clinics.
  • Abbott Laboratories expanded its infertility testing portfolio with a home-based ovulation testing kit, improving convenience for users.
  • Fertility Focus Ltd. received FDA approval for its latest fertility monitoring product, targeting female infertility diagnostics.
  • Menarini Diagnostics unveiled a new laboratory-based fertility testing solution that provides faster and more comprehensive results for both male and female patients.

List of Leading Companies:

  • Thermo Fisher Scientific Inc.
  • CooperSurgical Inc.
  • Abbott Laboratories
  • Sigma-Aldrich (Merck KGaA)
  • Fertility Focus Ltd.
  • LIFE Worldwide
  • BioTech Medical (Hologic)
  • Ortho Clinical Diagnostics
  • Genova Diagnostics
  • LabCorp
  • Beckman Coulter
  • Menarini Diagnostics
  • Vitrolife AB
  • ELITechGroup
  • Roche Diagnostics

Report Scope:

Report Features

Description

Market Size (2024-e)

USD 1.2 Billion

Forecasted Value (2030)

USD 2.2 Billion

CAGR (2025 – 2030)

10.8%

Base Year for Estimation

2024-e

Historic Year

2023

Forecast Period

2025 – 2030

Report Coverage

Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments

Segments Covered

Global Infertility Testing Market by Test Type (Ovulation Testing Kits, Hormonal Testing Kits, Semen Analysis Kits); Application (Female Infertility Testing, Male Infertility Testing); End-Use Industry (Fertility Clinics, Hospitals, Diagnostic Laboratories) and by Region

Regional Analysis

North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa)

Major Companies

Thermo Fisher Scientific Inc., CooperSurgical Inc., Abbott Laboratories, Sigma-Aldrich (Merck KGaA), Fertility Focus Ltd., LIFE Worldwide, Ortho Clinical Diagnostics, Genova Diagnostics, LabCorp, Beckman Coulter, Menarini Diagnostics, Vitrolife AB, Roche Diagnostics

Customization Scope

Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements

1. Introduction

   1.1. Market Definition

   1.2. Scope of the Study

   1.3. Research Assumptions

   1.4. Study Limitations

2. Research Methodology

   2.1. Research Approach

      2.1.1. Top-Down Method

      2.1.2. Bottom-Up Method

      2.1.3. Factor Impact Analysis

  2.2. Insights & Data Collection Process

      2.2.1. Secondary Research

      2.2.2. Primary Research

   2.3. Data Mining Process

      2.3.1. Data Analysis

      2.3.2. Data Validation and Revalidation

      2.3.3. Data Triangulation

3. Executive Summary

   3.1. Major Markets & Segments

   3.2. Highest Growing Regions and Respective Countries

   3.3. Impact of Growth Drivers & Inhibitors

   3.4. Regulatory Overview by Country

4. Infertility Testing Market, by Test Type (Market Size & Forecast: USD Million, 2023 – 2030)

   4.1. Ovulation Testing Kits

   4.2. Hormonal Testing Kits

   4.3. Semen Analysis Kits

   4.4. Others

5. Infertility Testing Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030)

   5.1. Female Infertility Testing

   5.2. Male Infertility Testing

6. Infertility Testing Market, by End-Use Industry (Market Size & Forecast: USD Million, 2023 – 2030)

   6.1. Fertility Clinics

   6.2. Hospitals

   6.3. Diagnostic Laboratories

7. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030)

   7.1. Regional Overview

   7.2. North America

      7.2.1. Regional Trends & Growth Drivers

      7.2.2. Barriers & Challenges

      7.2.3. Opportunities

      7.2.4. Factor Impact Analysis

      7.2.5. Technology Trends

      7.2.6. North America Infertility Testing Market, by Test Type

      7.2.7. North America Infertility Testing Market, by Application

      7.2.8. North America Infertility Testing Market, by End-Use Industry

      7.2.9. By Country

         7.2.9.1. US

               7.2.9.1.1. US Infertility Testing Market, by Test Type

               7.2.9.1.2. US Infertility Testing Market, by Application

               7.2.9.1.3. US Infertility Testing Market, by End-Use Industry

         7.2.9.2. Canada

         7.2.9.3. Mexico

    *Similar segmentation will be provided for each region and country

   7.3. Europe

   7.4. Asia-Pacific

   7.5. Latin America

   7.6. Middle East & Africa

8. Competitive Landscape

   8.1. Overview of the Key Players

   8.2. Competitive Ecosystem

      8.2.1. Level of Fragmentation

      8.2.2. Market Consolidation

      8.2.3. Product Innovation

   8.3. Company Share Analysis

   8.4. Company Benchmarking Matrix

      8.4.1. Strategic Overview

      8.4.2. Product Innovations

   8.5. Start-up Ecosystem

   8.6. Strategic Competitive Insights/ Customer Imperatives

   8.7. ESG Matrix/ Sustainability Matrix

   8.8. Manufacturing Network

      8.8.1. Locations

      8.8.2. Supply Chain and Logistics

      8.8.3. Product Flexibility/Customization

      8.8.4. Digital Transformation and Connectivity

      8.8.5. Environmental and Regulatory Compliance

   8.9. Technology Readiness Level Matrix

   8.10. Technology Maturity Curve

   8.11. Buying Criteria

9. Company Profiles

   9.1. Thermo Fisher Scientific Inc.

      9.1.1. Company Overview

      9.1.2. Company Financials

      9.1.3. Product/Service Portfolio

      9.1.4. Recent Developments

      9.1.5. IMR Analysis

    *Similar information will be provided for other companies 

   9.2. CooperSurgical Inc.

   9.3. Abbott Laboratories

   9.4. Sigma-Aldrich (Merck KGaA)

   9.5. Fertility Focus Ltd.

   9.6. LIFE Worldwide

   9.7. BioTech Medical (Hologic)

   9.8. Ortho Clinical Diagnostics

   9.9. Genova Diagnostics

   9.10. LabCorp

   9.11. Beckman Coulter

   9.12. Menarini Diagnostics

   9.13. Vitrolife AB

   9.14. ELITechGroup

   9.15. Roche Diagnostics

10. Appendix  

A comprehensive market research approach was employed to gather and analyze data on the Infertility Testing Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Infertility Testing Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.

Research Approach -

Secondary Research

Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.

Primary Research

Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:

  • Validating findings and assumptions derived from secondary research
  • Gathering qualitative and quantitative data on market trends, drivers, and challenges
  • Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
  • Assessing the supply-side landscape, including technological advancements and recent developments

Market Size Assessment

A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Infertility Testing Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:

  1. Identification of key industry players and relevant revenues through extensive secondary research
  2. Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
  3. Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources

Bottom Up and Top Down -

Data Triangulation

To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.

NA

Please state your requirements.


I have read the Terms & Conditions and Privacy Policy. I agree to its terms.

Report Buying Options